Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, announced the publication ...

As the FDA unveils a parade of initiatives aimed at accelerating drug development for rare diseases, experts appeal for a ...

Downing several strong energy drinks every day may pose a serious stroke risk, doctors have warned in the journal BMJ Case ...

Despite modern scientists identifying mercury as a hazardous environmental pollutant and one of the world 39;s most dangerous elemental toxins, mercury was once accepted as a miraculous substance ...

A recent case study highlights a serious stroke risk linked to excessive energy drink consumption. A man who drank eight ...

Traveling at high altitude can be hazardous. The information provided here is designed for educational use only and is not a substitute for specific training or experience. Princeton University and ...

Their data suggests that tweaking the expression of FDX2 could make up for the loss of frataxin, the protein tied to FA's development.

Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...